Previous close | 402.50 |
Open | 406.42 |
Bid | 410.13 x 100 |
Ask | 410.41 x 100 |
Day's range | 394.03 - 415.67 |
52-week range | 320.01 - 448.40 |
Volume | |
Avg. volume | 1,036,791 |
Market cap | 106.03B |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | 29.53 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Vertex stock advanced Tuesday as analysts debated the company's pain drug with one saying it could eventually generate $11.4 billion in sales.
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Q1 2024 Earnings Call Transcript May 6, 2024 Vertex Pharmaceuticals Incorporated beats earnings expectations. Reported EPS is $4.76, expectations were $4.07. Vertex Pharmaceuticals Incorporated isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, and welcome […]
Q1 2024 Vertex Pharmaceuticals Inc Earnings Call